Biarritz Meeting. 12th International Congress
|
|
|
- Phyllis Sparks
- 10 years ago
- Views:
Transcription
1 Biarritz Meeting 12th International Congress Addictions - Hepatitis - AIDS - (ATHS) Program September 29 - October 2nd, 2015 Bellevue Center of Congress - Biarritz plenary sessions, debates, workshops, posters twitter.com/thsbiarritz facebook.com/aths.biarritz
2 Tuesday september 29 th pm : Under the High Patronage of Opening In the presence of Solange MENIVAL, vice President of the Regional counsil of Aquitaine, of Michel LAFORCADE, Directeur général de l Agence Régionale de Santé Aquitaine, and of Michel VEUNAC, Mayor of Biarritz pm : simultaneously translated Conference/Debate : Hepatitis C, DAAs and public health : treating, who and when, and at what price? Victor de LEDINGHEN (Bordeaux), Christian TREPO (Lyon), Pascal MELIN (SOS Hépatites Saint Dizier), Jean-François CORTY (Médecins du Monde Paris), Daniel DHUMEAUX (Paris), Eberhard SCHATZ (Amsterdam) As a tribute to : Alain ROUSSET Président de la Région Aquitaine Jean-Jacques LASSERRE Président du Conseil Général des Pyrénées-Atlantiques Michel VEUNAC Maire de Biarritz Michel LAFORCADE Directeur général de l Agence Régionale de Santé Aquitaine Under the Honorary Presidency of Pr Françoise BARRE-SINOUSSI (Paris) Under the Presidency of Charles O BRIEN (Philadelphie) Christian TREPO (Lyon) Under the Direction of Jean-Pierre DAULOUEDE (Bayonne) General Secretory, Director of the Congress Arkaitz AGUERRETXE COLINA (Bayonne) Assistant General Secretory, Assistant Director of the Congress Marc AURIACOMBE (Bordeaux) Chairman of the scientific Comitee In collaboration with Jean-Marie Guffens Jean-Jacques DEGLON (Genève) President of the SETHS Pierre Pradier N enregistrement organisme : 2132 Développement professionnel continu : Association Nationale des Généralistes pour la Recherche et l Étude sur les Hépatopathies Chroniques graphisme : delfi[email protected] Partnerships :
3 Wednesday september 30 th am : Auditorium 1 - simultaneously translated Addictions Co-chair : Jean-Jacques DEGLON (Genève), Charles O BRIEN (Philadelphie) Moderation : Marc AURIACOMBE (Bordeaux) Addiction and gene-environment interaction / Mickaël NAASSILA (Amiens) Gene Variants Recently Identified as Associated with Opioid Addictions / Mary Jeanne KREEK (New York) Methadone and buprenorphine, safety issues / Adrian DUNLOP (Sidney) Addictions and sleep / Maurice DEMATTEIS (Grenoble) am pm : Auditorium - simultaneously translated am : break Brain substrates of relapse vulnerability : imaging the brain during cue - induced drug motivation («GO!») Anna Rose CHILDRESS (Philadephie) New therapeutics in addiction treatment / Ivan MONTOYA (Bethesda) Patient quality of life : for better and not for worse / Patrick MARTIN (Paris) Violence against women with subtsance abuse / Gabriele FISCHER (Vienne) pm : Auditorium - simultaneously translated Indivior Symposium : Opioid analgesics addiction in patients experiencing pain Moderation : Marc AURIACOMBE (Bordeaux) Current state and screening / Serge PERROT (Paris) Identifying the different profiles of opioid analgesic misuses / Nicolas AUTHIER (Clermont-Ferrand) Management of opioid analgesic dependence : which place for substitution therapy? / Maurice DEMATTEIS (Grenoble) pm : Auditorium - simultaneously translated Dual disorders Co-chair : Mehdi PAES (Rabat), Miguel CASAS (Barcelone) Moderation : Amine BENYAMINA (Paris) ADHD in opiate addicted patients : assessment and clinical features Constanza DAIGRE (Barcelone) Suicidal risk in gamblers asking for care Morgane GUILLOU LANDREAT (Nantes) Towards a specific psychopathology of heroin addiction Icro MAREMMANI (Pise) Gender influence and Dual Diagnosis in opiate-dependent patients / Carlos RONCERO (Barcelone) Rhune 1 - simultaneously translated Injectables opioids Co-chair : Nicolas AUTHIER (Clermont-Ferrand), Ambros UCHTENHAGEN (Zurich) Moderation : Miguel VELAZQUEZ (Paris) The function and role of heroin assisted treatment at the treatment system level / Ambros UCHTENHAGEN (Zurich) Morphine sulfate : «replacement or pleasure : do we have to choose»? Contradictory debate Nicolas AUTHIER (Clermont-Ferrand), Miguel VELAZQUEZ (Paris) Injectable buprenorphine : what are users s expectations? Perrine ROUX (Marseille) Naloxone, an antagonist to prevent and treat overdoses Jean-Michel DELILE (Bordeaux) pm : lunch break, poster session pm : break pm : Rhune 2 Abbvie Symposium : Care of Chronic HCV drug users in prisons and addiction clinics From clinical practice to patient experience Fadi MEROUEH (Villeneuve-lès-Maguelonne) pm : Vagues 3+4 Workshop 1 : An alternative to drug consumption rooms Chair : Serge LONGERE (Paris) Yann GRANGER (Marseille), Pascal PEREZ (Montreuil) Diane LESBOUEYRIES (Montreuil), David MICHELS (Paris) Vagues 1+2 Workshop 2 : Innovative clinical experiences in hepatology Co-chair : Véronique LATOUR (Bordeaux), Jean-Philippe LANG (Strasbourg) Chronic HCV : what are the new missions for psychiatrists and addiction specialists? / Jean-Philippe LANG (Strasbourg) Creation of a pedagogic tool based on an hepatitis talking group Fadila DEHAS (Montpellier), Caroline ALARCOS (Montpellier) Delivery of HCV treatment in harm reductions centers Véronique LATOUR (Bordeaux) Dynamics of viral C infection in drugs users in addiction clinics / Clotilde DUBURQUE (Lille) Does social vulnerability take part in HBV, HCV and HIV screening and access to HBV vaccination in IVDU in addiction clinics? / Fiorant DI-NINO (Strasbourg)
4 Wednesday september 30 th 2015/ following Auditorium - simultaneously translated Cannabinoids : research, clinics and use Co-chair : Amine BENYAMINA (Paris), Michel REYNAUD (Paris) Cannabis : Ethics and the Law Wim VAN DEN BRINK (Amsterdam) Cannabis Social Clubs Joan COLOM (Barcelone) Impact of regular cannabis use on the brain : interest of visual markers Vincent LAPREVOTE (Nancy) Rhune 1 - simultaneously translated Innovations in harm reduction in France Chair : Jean-François CORTY (Médecins du Monde Paris) Individual support and education on the harms associated with injection : place of common knowledge and issues of community research Marie JAUFFRET-ROUSTIDE (Paris) Take home naloxone : an action of common sense Jean-Pierre LHOMME (Paris) Rapid Diagnostic tests : a complementary tool close to exposed populations Marie-Dominique PAUTI (Paris) Patent opposition, acting for a real universal access to HCV treatment Olivier MAGUET (Paris) pm : The «Fabrique du funambule» presents : 911 and a bit more... A lecture and then, characters to meet, to discover and not to let go... Keep the line available, this is an emergency call. Textes and acting : Twins (small) Towers Artistic conception : Little Man, Businessman, Cosmic girl pm : Rhune 2 Workshop 1 : Harm reduction in tobacco use Moderation : Anne BORGNE (Paris) Electronic cigarette - legislation, politics, science : were do we stand? / Brice LEPOUTRE (Paris) Electronic cigarette in harm reduction centers Agnès LABORDE (Montreuil) Electronic cigarette use in Korsakoff patients Philippe MICHAUD (Villeneuve-la-Garenne) Vagues 1+2 Workshop 2 : Prisons Moderation : Saadia YAKOUB (Paris), Fadi MEROUEH (Villeneuve-lès-Maguelonne) First results of a sociological research on practices and perceptions of harm reduction in carceral environment Marie JAUFFRET ROUSTIDE (Paris) Availability and accessibility of harm reduction tools in prisons of 5 europeans states (data from the Pride Europe Study) : implications in public health Laurent MICHEL (Paris) Inmates rights and HIV infection Mohamed SOUMAH (Dakar) Out of prison unit : towards a continuity of cares in and out Véronique LATOUR (Bordeaux) HCV : knowledge, false beliefs and risky behavior in exprisoners and canadian control group Evelyne VALLIERES (Québec) How to improve internal communications in european prisons : Rehab project Fabio STERNBERG (Madrid) Vagues 3+4 Workshop 3 : Innovative clinical experiences in addictology Moderation : Eliane HERRAN (Bayonne) Relevance of motivational interviewing associated technics in adolescent cannabis users Jacques BERGERON (Montréal) Alcohol Marketing and alcohol use disorders Morgane GUILLOU (Nantes) Assessment of a cocaine and psychostimulants abstinence program in an addiction hospital Etienne POT (Lyon) Abuse of anabolic steroids in athletes : a bibliometric analysis / Victor AGULLO (Valencia) Learn in group how to channel one s anger Jean-Marie ROSSIER (Genève) Sexual addictions : therapeutic strategies to readjust a compulsive sexuality / Marthylle LAGADEC (Paris)
5 Thursday october 1 st am : Auditorium - simultaneously translated am : Rhune 1 Drug use and infectious risks : HIV - HCV co infections HIV/HCV Lecture : Addiction to death / Marc REISINGER (Bruxelles) Co-chair : Jacques NORMAND (Bethesda), Christian TREPO (Lyon), Jean-François DELFRAISSY (Paris) Injection Drug Users and HIV : not Time to Declare Victory Jacques NORMAND (Bethesda) Reducing HIV incidence among people who inject drugs (PWID) in Ukraine : results from a peer-based network intervention / Robert BOOTH (Denver) Hepatitis C treatments : four aces game Christian TREPO (Lyon) Simplified diagnostics - the key to success Tanya APPLEGATE (Sidney) Interest of Ag Core quantification in HCV for the screening of chronic hepatitis C Karine LACOMBE (Paris) / Léa DUCHESNE (Paris) Challenges to Implement Integrated HCV Prevention Services / Jason FARRELL (Amsterdam) Eradicate coinfections Pascal MELIN (Saint Dizier) am : Rhune 1 - simultaneously translated Opioids : new paths Co-chair : Mary Jeanne KREEK (New York), Charles O BRIEN (Philadelphie) Moderation : Marc REISINGER (Bruxelles) Psychiatric comorbidities in opioid-dependent patients : the influence on methdone doses Carlos RONCERO (Barcelone) Current status of Mu Opioid Receptor Directed Treatments for Opioid Addiction and a New Target for Novel Treatments of Cocaine Addiction and Adjunctive Treatment of Other Addictions Mary Jeanne KREEK (New York) SROM (slow release oral morphine) - an add-on medication for opioid dependence : risks & benefits Gabriele FISCHER (Vienne) A new method for relapse prevention in opiate addiction : slow release naltrexone Charles O BRIEN (Philadelphie) am pm : break pm : Auditorium - simultaneously translated Gilead Symposium : Multidisciplinary care : a key for HCV treatment in DU Moderation : Elisabeth AVRIL (Paris), Frédéric CHAFFRAIX (Strasbourg) Introduction : Presentations and discussions of multidisciplinary collaborations in the patient care pathway / Frédéric CHAFFRAIX (Strasbourg) Experience of Strasbourg s microstructures / Jean-Philippe LANG (Strasbourg) CSAPASCAN experience / Brigitte REILLER (Bordeaux) Mobile team in Perpignan / André-Jean REMY (Perpignan) Conclusion / Elisabeth AVRIL (Paris) h30 pm : lunch break, poster session ATHS 2013
6 Thursday october 2 nd 2015 / following Auditorium - simultaneously translated Alcohol, today and tomorrow Chair : Amine BENYAMINA (Paris) French and european recommandations Karl MANN (Mannheim) Focus on treatments Benjamin ROLLAND (Lille) Focus on alcohol research Nicolas SIMON (Marseille) Binge drinking un adolescence : cerebral consequences and addiction vulnerability, results from the european Alcobinge project / Mickael NAASSILA (Amiens) Rhune 1 - simultaneously translated Should Food/Eating Addiction replace current Eating Disorders? Chair : Charles O BRIEN (Philadelphie) Moderation : Marc AURIACOMBE (Bordeaux) Mélina FATSEAS (Bordeaux), Anna Rose CHILDRESS (Philadelphie) Charlotte KERVAN (Bordeaux), Julie COLLOMBAT (Bordeaux) pm : pm : break Vagues 3+4 Workshop 1 : Place of firstline stakeholders in addictology : general practitioners, pharmacists, work medicine : from early screening to long term follow up Moderation : Xavier AKNINE (Bondy) Pharmaddict : Place of the pharmacist Stéphane ROBINET (Paris) Clinical presentations on the role of GP Françoise ETCHEBAR (Pau), Bruno JOURNE (Paris) Presentation of the website «Intervenir Addictions» Dominique DE MUIZON (Chauny) Vagues 1+2 Workshop 2 : Is Hep C treatment an harm reduction tool? Presentation of SOS Hepatitis national survey Moderation : Pascal MELIN (Saint Dizier) Round table : Hélène DELAQUAIZE (Paris), Frédéric CHAFFRAIX (Strasbourg), Nathalie KRAICHETTE (Charleville-Mézières) Rhune 2 Workshop 3 : Is what we see when we look at drug users true to their reality? Philippe CHOSSEGROS (Lyon), Agnès CADET TAIROU (Paris), Jean-Pierre COUTERON (Paris), Fiorant DI NINO (Strasbourg), Fabrice OLIVET (Paris) pm : Auditorium - en traduction simultanée Panel/Debate Is war on drugs a failure? What are the alternatives? ANIMATION : Christophe HONDELATTE (Paris) With : Milton ROMANI GERNER / Elena LAGOMARSINO, Junta Nacional de Drogas, Presidencia de la Republica, Montevideo Thomas KERR, PhD, Director, Urban Health Research Initiative, British Columbia Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver Robert BOOTH, PhD, Clinical Professor of Psychiatry, Denver Javier SAGREDO, Advisor, Democratic Governance and Citizen Security, Regional Bureau for Latin America and the Caribbean, United Nation Development Programme, New York Juan DEL POZO, Coordinador General de la Cooperacion Española en el Uruguay, Agencia Española de Cooperacion International para el Desarrollo (AECID), Montevideo Patrick AEBERHARD, former President and creator of Doctors of the World, co-creator of IHRA, former Counselor at the Ministry of Health pm : Meeting Dinner, Plaza Berri 42 Avenue du Maréchal Foch, Biarritz
7 Friday october 1 st am : Auditorium - simultaneously translated Community research Chair : Perrine ROUX (Marseille) Engaging People who use Drugs in Research : Experiences from the Urban Health Research Initiative Thomas KERR (Vancouver) Research with community actors : the AERLI example / Perrine ROUX (Marseille) Ipergay and Slam : results and perspectives of 2 community research / Daniela ROJAS CASTRO (Paris) am : break am pm : Auditorium - simultaneously translated Drug policies Co-chair : Joan COLOM (Barcelone), Thomas KERR (Vancouver) Meta addictology : from street to recovery / Jacques BESSON (Lausanne) Evolution of the french harm reduction model / Marie JAUFFRET ROUSTIDE (Paris) Evolution of the danish harm reduction model / Esben HOUBORG (Copenhague) Drug policies and human rights / Javier SAGREDO (New York) Role of international cooperation in the approach and development of drug policies / Juan DEL POZO (Montevideo) pm : lunch break, poster session ATHS 2013 With the support of :
8 Friday october 1 st 2015 / following Auditorium - simultaneously translated Substance use disorders, HIV, HCV, in resource limited countries : the case of Vietnam Co-chair : Gilles RAGUIN (Paris), Don DES JARLAIS (New York), Le Minh GIANG (Hanoi) Moderation : Didier LAUREILLARD (Paris) Substance use disorders in Vietnam since «Doi Moi» (Renovation) : an epidemiologiocal overview and update on national program Le Minh GIANG (Hanoi) Community supported respondent driven sampling among PWID in Hai Phong : a case study with implications for intervention Don DES JARLAIS (New York) Results DRIVE-IN follow-up in Hai-Phong Nicolas NAGOT (Montpellier) Results and follow up of the Integrated treatment for opiate addiction and HIV in HCMC David METZGER (Philadelphie) Rhune 1 - simultaneously translated Tobacco and dual diagnosis (Société Française de Tabacologie) Moderation : Didier TOUZEAU (Paris) Tobacco and suicidal behaviours Ivan BERLIN (Paris) Tobacco and anxiety Mélina FATSEAS (Bordeaux) Tobacco care in psychiatric clinic : an update Nathalie WIRTH (Paris) Tobacco consulting for patients and workers of psychiatric hospital Didier TOUZEAU (Paris) pm : Rhune 2 Workshop 1 : Role of hospital addiction mobile team : screening, orientation and link in and around the hospital Chair : Pierre POLOMENI (Paris) Moderation : Gérard CAMPAGNE (Bayonne) Addiction mobile hospital team : reconciling E Health and mobility. Test and perspectives in Dordogne Anivel RAMOS (Périgueux) Screening and patients orientation of adult and children patients in a mother and child hospital in Paris Emmanuelle PEYRET (Paris) Place of addiction mobile hospital teams in the Pyrénées Orientales area Bénédicte DELMAS (Perpignan) pm : Closing Session Vagues 1+2 Workshop 2 : prevention of risky behaviors : action at all ages Moderation : Nicolas BONNET (Paris) Unplugged, an efficient prevention program in the Nord 92 Laëtitia USUBELLI (Clichy) Motivationnal interviewing with young adults : a pilot program in Rhone Alpes region Anne Cécile CORNIBERT (Paris) Representative students, guide of party nights and «le Plan B» web site : prevention by and for students Anne-Cécile RAHIS (Bordeaux) Vagues 3+4 Workshop 3 : Harm reduction and precariousness Presentation of the movie «RDR 2» from Philippe Lachambre and Laurent Appel, (51 mn) Followed by a discussion : Reducing harms or reducing social divide? Moderation : Fabrice OLIVET (Paris) Céline OYHENARD (Gagny), Valère ROGISSART (Paris)
TUESDAY OCTOBER, 11st WEDNESDAY OCTOBER, 12ND
FROM OCTOBER 11 to 14, 2011 BELLEVUE CENTER OF CONGRESS, BIARRITZ THS 10 SCHEDULE (may be changed) TUESDAY OCTOBER, 11st 5-7 PM : THS10 CONGRESS OPENING SESSION 5PM DEBATE/CONFERENCE 7PM END 9AM PLENARY
11th International Congress
11th International Congress From October 8 to 11, 2013»»» Bellevue Center of Congress Biarritz - France www.ths-biarritz.com /// Plenary sessions /// Debates /// Workshops /// Posters Addiction Hepatitis
Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction
Outline Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction About Substance Abuse The Cost of Chemical Abuse/Addiction Society's Response The Continuum of Chemical Use Definitions of Terms
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry
HEROIN AND RELATED OPIATES
HEROIN AND RELATED OPIATES DAVID J. NUTT Psychopharmacology Unit, Bristol University Heroin is a derivative of morphine and both belong to a large family of drugs called the opiates, that were originally
Clinical Priorities for Alcohol and Drugs in Public Health
Clinical Priorities for Alcohol and Drugs in Public Health What do we need to Measure up to? Dr Michael Kelleher Clinical Lead Alcohol and Drugs Team, Health and Wellbeing Directorate SMMGP 8 th Primary
Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances
page 1/5 Scientific Facts on Psychoactive Drugs Tobacco, Alcohol, and Illicit Substances Source document: WHO (2004) Summary & Details: GreenFacts Context - Psychoactive drugs such as tobacco, alcohol,
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Introduction Indication/Licensing information: Naltrexone is licensed for use as an additional therapy, within
Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.
Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize
EPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center
Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center 1 in 4 Americans will have an alcohol or drug problems at some point in their lives. The number of alcohol abusers and addicts
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community Dr David Jackson Clinic Medical Officer The Hobart Clinic Association Drugs In tonight s context, drugs
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
How To Treat An Addict
Guidance on Medical Treatment of Drug Abusers in Substitution Treatment for Opioid Dependency Pompidou Treatment Platform, Cyprus, May 2009 Helle Petersen Senior Medical Officer National Board of Health
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course
The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,
MORTALITY AMONGST ILLICIT DRUG USERS
MORTALITY AMONGST ILLICIT DRUG USERS Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
Medication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,
Rekindling House Dual Diagnosis Specialist
Rekindling House Dual Diagnosis Specialist Tel: 01582 456 556 APPLICATION FOR TREATMENT Application Form / Comprehensive Assessment Form Please provide as much detail as you can it will help us process
Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia
Alcohol and Drug A Cochrane Handbook losief Abraha MD Regional Health Perugia of Cristina Cusi MD Outpatient Services - Neurology Clinical Institutes of Specialisation Milan Italy A John Sons, Ltd., THE
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011 This document is intended to be used with the Somerset Dual Diagnosis Operational Working guide. This document provides principles governing joint working
Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
Treatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
DrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use
Petrol, paint and other Polydrug inhalants use 237 11 Polydrug use Overview What is polydrug use? Reasons for polydrug use What are the harms of polydrug use? How to assess a person who uses several drugs
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate
Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania
Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective
Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis
The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,
Addiction Psychiatry Fellowship Rotation Goals & Objectives
Addiction Psychiatry Fellowship Rotation Goals & Objectives Table of Contents University Neuropsychiatric Institute (UNI) Training Site 2 Inpatient addiction psychiatry rotation.....2 Outpatient addiction
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
Assessment and Diagnosis of DSM-5 Substance-Related Disorders
Assessment and Diagnosis of DSM-5 Substance-Related Disorders Jason H. King, PhD (listed on p. 914 of DSM-5 as a Collaborative Investigator) [email protected] or 801-404-8733 www.lecutah.com D I S C L
Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD
Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem Thomas Kosten MD Waggoner Chair & Professor of Psychiatry & Neuroscience Baylor College of Medicine Past-President,
John R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
Testimony of The New York City Department of Health and Mental Hygiene. before the
Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid
SROM (oral morphine) an add on medication for the treatment of opioid dependence: risks & benefits. Gabriele Fischer. Medical University Vienna
ATHS Biarritz oct 1 th, 2015 SROM (oral morphine) an add on medication for the treatment of opioid dependence: risks & benefits Gabriele Fischer [email protected] Medical University Vienna
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW
1 THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW By Dr. Des Crowley, General Practitioner INTRODUCTION The Drug Detox Unit was opened in July 1996 at Mountjoy Prison in response to the escalating drug
TREATMENT MODALITIES. May, 2013
TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.
Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
Frequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
Use of Vivitrol for Alcohol and Opioid Addiction
Use of Vivitrol for Alcohol and Opioid Addiction Ken Bachrach, Ph.D. Clinical Director, Tarzana Treatment Centers, Inc. [email protected] What is Vivitrol? An injectable from of naltrexone, which
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse
Attachment B NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE Psychosocial interventions in drug misuse On 16 th June 2004 the Department of Health
Department of Psychiatry & Health Behavior. Medical Student Electives in Psychiatry 2014-2015
Department of Psychiatry & Health Behavior If you are interested in declaring psychiatry as your area of interest, please contact Dr. Adriana Foster ([email protected]). Medical Student Electives in Psychiatry
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
Wednesday, March 7 th Genealogy and actuality of research. 9 : 00 am Opening Remarks (by Officials)
Wednesday, March 7 th Genealogy and actuality of research 9 : 00 am Opening Remarks (by Officials) 9 : 30 am - Interministerial Issues Regarding Access to Shelter and Housing for Homeless or Difficult
Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director
Heroin Overdose Trends and Treatment Options Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Type date here www.gatewayrehab.org Drug Overdose Deaths Increasing in Allegheny County Roberta Lojak holds
Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7)
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL
Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP
Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP Habit is habit, and not to be flung out of the window by any man, but coaxed down-stairs one step at a time. Samuel Langhorne Clemens
Co-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs
Co-Occurring Substance Use and Mental Health Disorders Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs Introduction Overview of the evolving field of Co-Occurring Disorders Addiction and
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
CLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12
Page: 1 of 7 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted
DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM
DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of
DEPARTMENT OF PSYCHIATRY. 1153 Centre Street Boston, MA 02130
DEPARTMENT OF PSYCHIATRY 1153 Centre Street Boston, MA 02130 Who We Are Brigham and Women s Faulkner Hospital (BWFH) Department of Psychiatry is the largest clinical psychiatry site in the Brigham / Faulkner
Allyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
Using Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
Co-morbid Mental Illness & Substance Abuse Challenges to Treatment
Co-morbid Mental Illness & Substance Abuse Challenges to Treatment Trecia Wouldes, PhD Department of Psychological Medicine Brown Research Center for the Study of Children at Risk Outline Extent of co-morbidity
Croydon Drug and Alcohol Services. Directory of drug and alcohol services available in Croydon
Croydon Drug and Alcohol Services Directory of drug and alcohol services available in Croydon April 2012 Croydon Treatment & Recovery Partnership Contact details Lantern Hall 190 Church Road Croydon CR0
Do we need special programs for aging drug users?
High risk drug use and drug treatment in Europe 2014 EMCDDA event: Continuity and Change Lisbon, 24-26 September 2014 Do we need special programs for aging drug users? Andrej Kastelic EUROPAD General Secretary
WEST LOTHIAN ADDICTION SERVICES DIRECTORY INFORMATION
WEST LOTHIAN ADDICTION SERVICES DIRECTORY INFORMATION PARENTING SUPPORT FOR FAMILIES WITH SUBSTANCE USING PARENTS Circle West Lothian Circle West Lothian, c/o Blackburn Homeless Unit, Blackburn, West Lothian
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7)
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL
Dual diagnosis: working together
Dual diagnosis: working together Tom Carnwath RCGP conference Birmingham 2007 DSM-IV & cocaine Cocaine intoxication Cocaine withdrawal Cocaine-induced sleep disorder Cocaine-induced sexual dysfunction
Addiction Pharmacotherapies in Integrated Systems OPIOIDS
Addiction Pharmacotherapies in Integrated Systems OPIOIDS Univ. Prof. Dr.. Gabriele Fischer Department of Psychiatry Addiction clinic Medical University Vienna DELIVERY SYSTEMS FOR SUBSTANCE ABUSE TREATMENT
How To Treat A Mental Illness At Riveredge Hospital
ABOUT US n Riveredge Hospital maintains the treatment philosophy of Trauma Informed Care. n Our commitment to providing the highest quality of care includes offering Animal Assisted Therapy, and Expressive
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule
Drugs and Addiction Policy in the Federal Republic of Germany
DRUG POLICY TODAY AND TOMORROW The Action Plan on Drugs & Addiction and its Implementation Finnish-German Media Seminar on Prescription Drugs as Addictions and Remedies September 5, 2008 Berlin, Germany
Drug Abuse and Addiction
Drug Abuse and Addiction Introduction A drug is a chemical substance that can change how your body and mind work. People may abuse drugs to get high or change how they feel. Addiction is when a drug user
Treatment Programs (OMTP)
Sponsored by: Continuing Medical Education Program best practices for Opiate Maintenance Treatment Programs (OMTP) Avoid Abuse, Limit Liability May 8-11, 2012 December 4-7, 2012 Case Western Reserve University
Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates
Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported
Understanding Addiction: The Intersection of Biology and Psychology
Understanding Addiction: The Intersection of Biology and Psychology Robert Heimer, Ph.D. Yale University School of Public Health Center for Interdisciplinary Research on AIDS New Haven, CT, USA November
Beyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry
Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer
Opioid Addiction & Corrections
Opioid Addiction & Corrections Medication Assisted Treatment in the Connecticut Department of Correction April 30, 2015--CJPAC Kathleen F. Maurer, MD, MPH, MBA Medical Director and Director of Health and
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
Opioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES
Course Description SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES At the end of this course participants will be able to: Define and distinguish between substance use, abuse and dependence
drug treatment in england: the road to recovery
The use of illegal drugs in England is declining; people who need help to overcome drug dependency are getting it quicker; and more are completing their treatment and recovering drug treatment in ENGlaND:
SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
University of the State of New York; New York State Licensed Psychologist Since 1983; #7640.
CHRISTOPHER JACOB REISS, B.A., M.A., PH.D. Offices 1440 York Avenue, New York, NY 10021 (212) 517-7755 Last Resort Farm, Scottsville, VA 24590 (434) 286-9000 Sea Oaks Club, Vero Beach, FL 32963 (561) 234-6323
UNODC World Drug Report 2016:
UNODC World Drug Report 2016: Launch in Geneva on 23 June 2016 Briefing to the Member States and Civil Society Organizations Remarks by Aldo Lale-Demoz, Deputy Executive Director, UNODC UNODC is honoured
Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts
Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts Educational Objectives: Review epidemiology of opioid addiction in
TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION
TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment
Co-occurring Disorder Treatment for Substance Abuse and Compulsive Gambling
Co-occurring Disorder Treatment for Substance Abuse and Compulsive Gambling Midwest Conference on Problem Gambling and Substance Abuse 2006 Problem Gambling and Co-occurrence: Improving Practice and Managing
